sc 58125 has been researched along with Glucose Metabolic Disorder in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brunette, E; Gendron, TF; Mealing, GA; Morley, P; Nguyen, A; Tauskela, JS | 1 |
1 other study(ies) available for sc 58125 and Glucose Metabolic Disorder
Article | Year |
---|---|
Opposing effects of cyclooxygenase-2 selective inhibitors on oxygen-glucose deprivation-induced neurotoxicity.
Topics: Animals; Calcium; Canada; Cell Death; Cells, Cultured; Cerebral Cortex; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytosol; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Enzyme Induction; Extracellular Space; Glucose Metabolism Disorders; Glutamates; Hypoxia; Mice; Mice, Inbred C57BL; Neurotoxicity Syndromes; Nitrobenzenes; Prostaglandin-Endoperoxide Synthases; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Sulfonamides; Time Factors | 2004 |